About this trial
Endometriosis is a systemic, steroid-dependent, inflammatory disease characterized by the growth of endometrial-like tissue outside the uterus, affecting approximately 10 % of women of childbearing age. The etiology and pathophysiology of endometriosis is not completely understood to support effective treatment and prevention strategies. Despite the steroid dependency, little is known concerning the underlying metabolism of estrogen and other tightly related steroids. Moreover, shortening the long diagnostic delays is a major priority in endometriosis research.
Eligibility criteria
Qualifiers
Women aged 18 to 45
Free, informed and written consent from the patient to participate in the study
Good understanding of the French language
Patient affiliated to or benefiting from a social security or similar scheme
Disqualifiers
Intercurrent diagnosis of pregnancy.
Presence of other hormone-dependent pathologies (e.g. breast cancer, PCOS).
Acute infection.
Trial design
Treatments tested in this trial
- Blood test
- urine sample
- vaginal sample